Modeling ferroptosis in human dopaminergic neurons: Pitfalls and opportunities for neurodegeneration research.

Ilinca Suciu, Stefan Schildknecht, Marcel Leist, Nadine Renner, Franziska Schöb, Regina Pape, Anna-Sophie Spreng, Anna-Katharina Ückert, Eike Cöllen, Federica Bovio, Bruno Chilian, Johannes Bauer, Stefan Röpcke, Jörg Bergemann

Journal: Redox biology 2024;73():103165

PMID: 38688061

Abstract

The activation of ferroptosis is being pursued in cancer research as a strategy to target apoptosis-resistant cells. By contrast, in various diseases that affect the cardiovascular system, kidneys, liver, and central and peripheral nervous systems, attention is directed toward interventions that prevent ferroptotic cell death. Mechanistic insights into both research areas stem largely from studies using cellular in vitro models. However, intervention strategies that show promise in cellular test systems often fail in clinical trials, which raises concerns regarding the predictive validity of the utilized in vitro models. In this study, the human LUHMES cell line, which serves as a model for human dopaminergic neurons, was used to characterize factors influencing the activation of ferroptosis. Erastin and RSL-3 induced cell death that was distinct from apoptosis. Parameters such as the differentiation state of LUHMES cells, cell density, and the number and timing of medium changes were identified as determinants of sensitivity to ferroptosis activation. In differentiated LUHMES cells, interventions at mechanistically divergent sites (iron chelation, coenzyme Q, peroxidase mimics, or inhibition of 12/15-lipoxygenase) provide almost complete protection from ferroptosis. LUHMES cells allowed the experimental modulation of intracellular iron concentrations and demonstrated a correlation between intracellular iron levels, the rate of lipid peroxidation, as well as the sensitivity of the cells to ferroptotic cell death. These findings underscore the importance of understanding the various factors that influence ferroptosis activation and highlight the need for well-characterized in vitro models to enhance the reliability and predictive value of observations in ferroptosis research, particularly when translating findings into in vivo contexts.

Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.

Address: Albstadt-Sigmaringen University, Faculty of Life Sciences, 72488, Sigmaringen, Germany.; In Vitro Toxicology and Biomedicine, Department of Biology, University of Konstanz, 78457, Konstanz, Germany.; Department of Biotechnology and Biosciences, University of Milano-Bicocca, 20126, Milano, Italy.; TRI Thinking Research Instruments GmbH, Große Freiheit 77, 22767, Hamburg, Germany.; Stemick GmbH, Byk-Gulden Str. 2, 78467, Konstanz, Germany.; Albstadt-Sigmaringen University, Faculty of Life Sciences, 72488, Sigmaringen, Germany. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.